Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clozapine and risperidone: refining and extending their use

P F Buckley1, S C Schulz

  • 1Department of Psychiatry, Case Western Reserve University, Cleveland, Ohio, USA.

Harvard Review of Psychiatry
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.

Translational psychiatry·2017
Same author

National institute of mental health clinical research career opportunities.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Same author

The impact of parent socio-economic status on executive functioning and cortical morphology in individuals with schizophrenia and healthy controls.

Psychological medicine·2013
Same author

Psychotherapy and schizophrenia.

The Journal of psychotherapy practice and research·2012
Same author

Latent structure of psychotic experiences in the general population.

Acta psychiatrica Scandinavica·2011
Same author

Striatal function in relation to negative symptoms in schizophrenia.

Psychological medicine·2011
Same journal

A Student-Faculty Collaboration: Embedding Trauma-Informed Care in Medical Education.

Harvard review of psychiatry·2026
Same journal

Inpatient Management of Benzodiazepine Withdrawal: A Narrative Review of a Systematic, Individualized Taper Design.

Harvard review of psychiatry·2026
Same journal

Application of mHealth Approaches to Increase Access to and Engagement of Mental Health Treatment Among Underserved Communities.

Harvard review of psychiatry·2026
Same journal

Integrating Climate Change and Mental Health into Medical Education: A Narrative Review of Interventions and Assessment Tools.

Harvard review of psychiatry·2026
Same journal

The Long Road Back: An Integrative and Interdisciplinary Approach to Care After Traumatic Brain Injury.

Harvard review of psychiatry·2026
Same journal

Poverty, Policy, and Mental Health Inequities: Evidence, Challenges, and Opportunities.

Harvard review of psychiatry·2026
See all related articles

Atypical antipsychotics like clozapine and risperidone offer new treatment options for schizophrenia. Research refines their use, explores new patient groups, and considers cost-benefit and psychosocial integration for improved psychosis management.

Area of Science:

  • Psychiatry and Pharmacology
  • Neuroscience
  • Clinical Psychology

Background:

  • Atypical antipsychotics represent advancements in treating schizophrenia and psychoses.
  • Clozapine and risperidone are key atypical antipsychotics currently used in the US.
  • Ongoing research focuses on optimizing their efficacy and expanding their applications.

Purpose of the Study:

  • To review current clinical applications and refinements in the use of clozapine and risperidone.
  • To explore novel uses of these atypical antipsychotics in specific patient subgroups.
  • To discuss cost-benefit analyses and the integration of these medications with psychosocial therapies.

Main Methods:

  • Literature review of clinical studies and pharmacological data on clozapine and risperidone.

Related Experiment Videos

  • Analysis of treatment refinements, including dosage, duration, and plasma level monitoring.
  • Examination of efficacy in diverse patient populations and comorbid conditions.

    • Main Results:

    • Refinements in clozapine use include optimal trial duration, dosage, and plasma level monitoring for efficacy.
    • Clozapine shows potential in new patient groups like first-episode schizophrenia, polydipsia, and dual diagnosis.
    • Risperidone's application is discussed for first-episode schizophrenia, affective disorders, and autism.

    Conclusions:

    • Optimized use of clozapine and risperidone enhances treatment for schizophrenia and related psychoses.
    • These atypical antipsychotics demonstrate versatility across various patient subgroups and comorbid conditions.
    • Integrating novel antipsychotics with psychosocial therapies may offer synergistic benefits for patient recovery.